Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors
Authors:
- Gerald S. FalchookGFGerald S. Falchook
- Karthik VenkatakrishnanKVKarthik Venkatakrishnan
- John SarantopoulosJSJohn Sarantopoulos
- Razelle KurzrockRKRazelle Kurzrock
- Alain C. MitaAMAlain C. Mita
- Siqing FuSFSiqing Fu
- Monica M. MitaMMMonica M. Mita
- Xiaofei ZhouXZXiaofei Zhou
- Jung Ah JungJJJung Ah Jung
- Claudio Dansky UllmannCUClaudio Dansky Ullmann
- Catherine MilchCMCatherine Milch
- Lee S. RosenLRLee S. Rosen
- 1 July 2015
- journal article
- research article
- Published by Dustri-Verlag Dr. Karl Feistle in Int. Journal of Clinical Pharmacology and Therapeutics
- Vol. 53 (7) , 563-572